BCTX - BriaCell Therapeutics Corp.
3.86
-0.150 -3.886%
Share volume: 186,040
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$4.01
-0.15
-0.04%
View ratios
| Fiscal Date | 01-31-2024 | 04-30-2024 | 07-31-2024 | 10-31-2024 | 01-31-2025 | 04-30-2025 | 07-31-2025 | 10-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 03-18-2024 | 06-14-2024 | 12-16-2024 | 12-16-2024 | 03-12-2025 | 06-16-2025 | 10-16-2025 | 12-11-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | |||||
| Operating expenses | 9.829 M | 9.230 M | 5.768 M | 5.153 M | 7.169 M | 6.328 M | 8.554 M | 8.323 M | |
| Selling general and admin | 1.572 M | 1.572 M | 1.362 M | 1.487 M | 1.485 M | 1.518 M | 1.444 M | 1.639 M | |
| Research and development | 8.257 M | 7.658 M | 4.405 M | 3.665 M | 5.685 M | 4.810 M | 7.110 M | 6.684 M | |
| Total expenses | 9.829 M | 9.230 M | 5.768 M | 5.153 M | 7.169 M | 6.328 M | 8.554 M | 8.323 M | |
| -6.10% | -37.51% | -10.66% | 39.14% | -11.73% | 35.18% | -2.70% | |||
| Operating income | -9.829 M | -9.230 M | -5.768 M | -5.153 M | -7.169 M | -6.328 M | -8.554 M | -8.323 M | |
| Ebit | -11.316 M | 1.729 M | -1.198 M | -5.769 M | -6.295 M | -6.162 M | -8.105 M | -8.233 M | |
| Pretax income | -11.316 M | 1.692 M | -1.267 M | -5.769 M | -6.338 M | -6.225 M | -8.224 M | -8.278 M | |
| -114.95% | -174.88% | 355.33% | 9.85% | -1.78% | 32.11% | 0.66% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -11.334 M | 1.692 M | -1.249 M | -5.829 M | -6.338 M | -6.225 M | -8.164 M | -8.278 M | |
| 114.93% | -173.79% | -366.81% | -8.72% | 1.78% | -31.15% | -1.40% |